>>12227641

moar sauce for that notable,Baker

https://www.pennlive.com/news/2020/12/us-attorney-david-freed-announces-resignation.html

U.S. Attorney in Pennsylvania David Freed announces resignation

"Once he resigns, First Assistant U. S. Attorney Bruce D. Brandler will assume the position of U.S. Attorney pursuant to the Vacancies Reform Act, according to the statement. Bandler has been with the U.S. Attorney’s office for more than 30 years and previously served as U. S. Attorney from 2016 to 2017.

The Middle District of Pennsylvania covers 33 Pennsylvania counties, all of which are located in central and northeast Pennsylvania. Federal courthouses in the Middle District are located in Harrisburg, Scranton, Wilkes-Barre, and Williamsport."

notable from last bread >>12227081

Carteret County schools had already called for remote learning until January 19, the Tuesday after MLK Jr. holiday.

Cherry Point MCAS going into active mission mode?

>>12227940

Baker

please merge the following collected notables:

>12227641 BREAKING: Top Federal Prosecutor Resigns After Pennsylvania Election Fraud Investigation

>12227760 U.S. Attorney in Pennsylvania David Freed announces resignation

TY, o7

>>12228035

Hard to characterize what occurred in Nashville as "false flag bullshit".

The very fact that all is silent is evidence of how real it actually was.

>>12228088

from Goldman to Moderna to venture capital at Wharton… Dr. Kim sure gets around

Lorence Kim, M.D.

Venture Partner

Third Rock Ventures

"Lorence Kim joined TRV as a venture partner in 2020. He was previously the Chief Financial Officer of Moderna, guiding $4.4 billion of capital raising to support the company’s platform efforts in mRNA medicines and the discovery and development of a pipeline of 20+ candidates across infectious disease, oncology, rare disease and autoimmune disease. Prior to Moderna, he was co-head of the US biotechnology investment banking effort at Goldman Sachs. He was a member of the Healthcare Investment Banking Group for nearly fourteen years. Lorence joined Goldman Sachs in 1999 as a summer associate, and was named managing director in 2008.

Among his M&A transactions are the sales of MedImmune to AstraZeneca for $15.6 bn, Millennium to Takeda for $8.8 bn, Human Genome Sciences to GlaxoSmithKline for $3.6 bn, Abgenix to Amgen for $2.9 bn, Medarex to Bristol-Myers Squibb for $2.5 bn, Myogen to Gilead for $2.5 bn, and Micromet to Amgen for $1.2 bn. His recent financings include transactions for Auxilium, Isis, Human Genome Sciences, Regeneron, Medarex, Cubist and Micromet.

Prior to joining Goldman Sachs, Lorence worked in various medical research and consulting positions concurrent with his graduate studies.

Lorence earned an AB in Biochemical Sciences, magna cum laude and Phi Beta Kappa, from Harvard University in 1995. He earned an MBA in Healthcare Management as a Palmer Scholar from the Wharton School of the University of Pennsylvania in 2000 and an MD from the University of Pennsylvania School of Medicine in 2000. He and his wife, Sherry, have three children and live in New York City."

>>12228175

from May 2020:

CROOKS: Two Moderna Executives Sold $30 million of Stock before Truth about Vaccine Trial Failure was Uncovered

https://fort-russ.com/2020/05/crooks-two-moderna-executives-sold-30-million-of-stock-before-truth-about-vaccine-trial-failure-was-uncovered/

Two executives at drug firm Moderna quietly sold nearly $30 million of stock when they unveiled a coronavirus vaccine and value surged, before the share price quickly fell again amid skepticism from the medical community.

Moderna’s chief financial officer Lorence Kim and chief medical officer Tal Zaks dumped the staggering value of stocks on Monday and Tuesday when the share price skyrocketed following the company’s announcement of what it described as ‘positive’ results from its vaccine trial.

The two executives pocketed almost $25 million in profits in a day’s work before experts cast doubt on the vaccine’s success and sent shares tumbling.

FRN reported on the false reports, citing an article written by Robert F. Kennedy Jr. that the Moderna vaccine results were a failure.

Fake fact checkers working for social media firms tagged FRN’s report as ‘false information’, insisting instead that the Moderna tests had been a success. Investors in biotech and pharma, and the virologists they depend on, apparently agreed with FRN’s assessment.